Monday, November 23, 2009

Oceanside Pharmaceuticals Announces Launch of Librax AG

Oceanside Pharmaceuticals, part of Valeant Pharmaceuticals International, today announced that it has now launched chlordiazepoxide hydrochloride and clidinium bromide, an authorized generic (AG) version of Librax®. Oceanside has received its first orders and expects to be a significant player in the Librax® generic market.

The details can be read here.

No comments: